Volume 27, Issue 3 (Avicenna Journal of Clinical Medicine-Autumn 2020)
Avicenna J Clin Med 2020, 27(3): 157-163 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Vahidinia A A, Mazdeh M, Adman S, Cheraghi Z. Comparison of the Patients Suffering from Relapsing-Remitting Multiple Sclerosis with Healthy Individuals regarding Serum Selenium and Zinc Levels. Avicenna J Clin Med 2020; 27 (3) :157-163
URL: http://sjh.umsha.ac.ir/article-1-2118-en.html
URL: http://sjh.umsha.ac.ir/article-1-2118-en.html
1- 1Professor, Department of Biochemistry and Nutrition, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
2- Professor, Department of Neurology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
3- General Practitioner, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran , saladin.adman94@gmail.com
4- Assistant Professor, Department of Epidemiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
2- Professor, Department of Neurology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
3- General Practitioner, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran , saladin.adman94@gmail.com
4- Assistant Professor, Department of Epidemiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
Abstract: (1802 Views)
Background and Objective: Multiple sclerosis is an autoimmune disease of the central nervous system that causes demyelination and axonal damage. There are contradictory results regarding the effects of zinc and selenium on the prevention or reduction of multiple sclerosis symptoms. This study aimed to compare selenium and serum zinc levels of the patients suffering from relapsing-remitting multiple sclerosis with those of healthy individuals.
Materials and Methods: This case-control study compared 30 patients suffering from relapsing-remitting multiple sclerosis (case) with 30 healthy individuals (control) regarding serum zinc and selenium levels. The cases and controls were matched in terms of age, gender, and smoking history using frequency matching methods. The data were analyzed using STATA software (version 15). A p-value less than 0.05 was considered statistically significant.
Materials and Methods: This case-control study compared 30 patients suffering from relapsing-remitting multiple sclerosis (case) with 30 healthy individuals (control) regarding serum zinc and selenium levels. The cases and controls were matched in terms of age, gender, and smoking history using frequency matching methods. The data were analyzed using STATA software (version 15). A p-value less than 0.05 was considered statistically significant.
Results: The mean ages of the patients in the case and control groups were 34.0±5.1 and 33.8±4.9 years (P=0.439), respectively. Moreover, the results revealed that the serum zinc and serum selenium levels were 110.86±21.32 and 83.60±10.71 micrograms/dl (P<0.001) as well as 78.58±17.75 and 85.61±24.18 micrograms/dl (P=0.102) in the case and control groups, respectively. Furthermore, disease duration and severity had a positive correlation with serum selenium level; however, it was not significant. On the other hand, serum zinc level was negatively correlated with disease duration and severity although it was not statistically significant.
Conclusion: Zinc deficiency seems to play a role in the pathogenicity of relapsing-remitting multiple sclerosis; however, it does not correlate with the disease severity and duration. Considering the low levels of serum selenium in patients with multiple sclerosis, this difference was not statistically significant and may have been affected by the sample size.
References
1. Kaminska J, Koper OM, Piechal K, Kemona H. Multiple sclerosis - etiology and diagnostic potential. Postepy Hig Med Dosw (Online). 2017;71:551-63. PMID: 28665284 DOI: 10.5604/01.3001.0010.3836
2. Nicholas R, Rashid W. Multiple sclerosis. Am Fam Physician. 2013;87(10):712-4. PMID: 23939450
3. 3. Sand IK, Benn EK, Fabian M, Fitzgerald KC, Digga E, Deshpande R, et al. Randomized-controlled trial of a modified Mediterranean dietary program for multiple sclerosis: a pilot study. Mult Scler Relat Disord. 2019;36:101403. PMID: 31610401 DOI: 10.1016/j.msard.2019.101403
4. Rotstein DL, Cortese M, Fung TT, Chitnis T, Ascherio A, Munger KL. Diet quality and risk of multiple sclerosis in two cohorts of US women. Mult Scler. 2019;25(13):1773-80. PMID: 30351179 DOI: 10.1177/1352458518807061
5. Ross AC, Caballero BH, Cousins RJ, Tucker KL, Ziegler TR. Modern nutrition in health and disease. 11th ed. Philadelphia: Wolters Kluwer Health Adis (ESP); 2012. P. 1616.
6. Mehra P, Wolford LM. Serum nutrient deficiencies in the patient with complex temporomandibular joint problems. Proc (Bayl Univ Med Cent). 2008;21(3):243-7. PMID: 18628971 DOI: 10.1080/08998280.2008.11928403
7. Socha K, Kochanowicz J, Karpińska E, Soroczyńska J, Jakoniuk M, Mariak Z, et al. Dietary habits and selenium, glutathione peroxidase and total antioxidant status in the serum of patients with relapsing-remitting multiple sclerosis. Nutr J. 2014;13(1):62. PMID: 24943732 DOI: 10.1186/1475-2891-13-62
8. Bredholt M, Frederiksen JL. Zinc in multiple sclerosis: a systematic review and meta-analysis. ASN Neuro. 2016;8(3):1759091416651511. PMID: 27282383 DOI: 10.1177/1759091416651511
9. Pawlitzki M, Uebelhör J, Sweeney-Reed C, Stephanik H, Hoffmann J, Lux A, et al. Lower serum zinc levels in patients with multiple sclerosis compared to healthy controls. Nutrients. 2018;10(8):967. PMID: 30049983 DOI: 10.3390/nu10080967
10. Ghazavi A, Kianbakht S, Ghasami K, Mosayebi G. High copper and low zinc serum levels in Iranian patients with multiple sclerosis: a case control study. Clin Lab. 2012;58(1-2):161-4. PMID: 22372359
11. Forte G, Visconti A, Santucci S, Ghazaryan A, Figà-Talamanca L, Cannoni S, et al. Quantification of chemical elements in blood of patients affected by multiple sclerosis. Ann Ist Super Sanita. 2005;41(2):213-6. PMID: 16244395
12. Alimonti A, Ristori G, Giubilei F, Stazi MA, Pino A, Visconti A, et al. Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis. Neurotoxicology. 2007;28(3):450-6. PMID: 17267042 DOI: 10.1016/j.neuro.2006.12.001
13. Kurzrock EA, Jegatheesan P, Cunha GR, Baskin LS. Urethral development in the fetal rabbit and induction of hypospadias: a model for human development. J Urol. 2000;164(5):1786-92. PMID: 11025770
14. Kaźmierczak K, Malukiewicz G, Lesiewska-Junk H, Laudencka A, Szady-Grad M, Klawe J, et al. Blood plasma levels of microelements in patients with history of optic neuritis. Curr Eye Res. 2014;39(1):93-8. PMID: 24083481 DOI: 10.3109/02713683.2013.833244
15. Alizadeh A, Mehrpour O, Nikkhah K, Bayat G, Espandani M, Golzari A, et al. Comparison of serum concentration of Se, Pb, Mg, Cu, Zn, between MS patients and healthy controls. Electron Physician. 2016;8(8):2759-64. PMID: 27757186 DOI: 10.19082/2759
16. Sedighi B, Ebrahimi HA, Haghdoost AA, Abotorabi M. Comparison of serum levels of copper and zinc among multiple sclerosis patients and control group. Iran J Neurol. 2013;12(4):125-8. PMID: 24250921
17. Dore-Duffy P, Catalanotto F, Donaldson JO, Ostrom KM, Testa MA. Zinc in multiple sclerosis. Ann Neurol. 1983;14(4):450-4. PMID: 6195958 DOI: 10.1002/ana.410140409
18. Knoell DL, Liu MJ. Impact of zinc metabolism on innate immune function in the setting of sepsis. Int J Vitam Nutr Res. 2010;80(4-5):271-7. PMID: 21462110 DOI: 10.1024/0300-9831/a000034
19. Mocchegiani E, Romeo J, Malavolta M, Costarelli L, Giacconi R, Diaz LE, et al. Zinc: dietary intake and impact of supplementation on immune function in elderly. Age (Dordr). 2013;35(3):839-60. PMID: 22222917 DOI: 10.1007/s11357-011-9377-3
20. Bruce E. No Episiotomy: Getting Through Birth in One Piece. New York: Peaceful Parenting; 2009.
21. Fathi F, Mehrpour M, Akbari ME, Sohrabzadeh K, Fathi S, Joghataie MT, et al. A concentration of serum selenium in multiple sclerosis patients compare to healthy subject in Tehran. J Paramed Sci. 2013;4(4):116-8.
22. Nasri NM, Shamohamadi R. Measurement of selenium level in blood of residents of Isfahan affected by multiple sclerosis. Razi J Med Sci. 2015;22(137):75-83.
23. Mazzella GL, Sinforiani E, Savoldi F, Allegrini M, Lanzola E, Scelsi R. Blood cells glutathione peroxidase activity and selenium in multiple sclerosis. Eur Neurol. 1983;22(6):442-6. PMID: 6662155 DOI: 10.1159/000115600
24. 24. Yu N, Han F, Lin X, Tang C, Ye J, Cai X. The association between serum selenium levels with rheumatoid arthritis. Biol Trace Element Res. 2016;172(1):46-52. PMID: 26581918 DOI: 10.1007/s12011-015-0558-2
25. Sahebari M, Rezaieyazdi Z, Khodashahi M. Selenium and autoimmune diseases: a review article. Currt Rheumatol Rev. 2019;15(2):123-34. PMID: 30324883 DOI: 10.2174/1573397114666181016112342
26. Kocyigit A, Erel O, Gur S. Effects of tobacco smoking on plasma selenium, zinc, copper and iron concentrations and related antioxidative enzyme activities. Clin Biochem. 2001;34(8):629-33. PMID: 11849622 DOI: 10.1016/s0009-9120(01)00271-5
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s).
Owned by Hamadan University of Medical Sciences
Published by UMSHA Press
Journal Tel: +988138380924
Publisher Tel:+988138380548
Website: http://sjh.umsha.ac.ir
Email: s_ journal[at]umsha.ac.ir
